Ownership history in STRS OHIO · 10 quarters on record
This page tracks every 13F SEC filing in which STRS OHIO reported a position in CELLDEX THERAPEUTICS INC (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 2,900 | -3,700 | -56.1% | 0.00% | $75K | $25.87 |
| 2024 Q2 | ADDED | 6,600 | +700 | +11.9% | 0.00% | $244K | $37.01 |
| 2024 Q1 | ADDED | 5,900 | +3,200 | +118.5% | 0.00% | $247K | $41.97 |
| 2023 Q4 | ADDED | 2,700 | +1,300 | +92.9% | 0.00% | $107K | $39.66 |
| 2023 Q3 | REDUCED | 1,400 | -5,100 | -78.5% | 0.00% | $38K | $27.52 |
| 2023 Q2 | ADDED | 6,500 | +500 | +8.3% | 0.00% | $220K | $33.93 |
| 2023 Q1 | ADDED | 6,000 | +4,800 | +400.0% | 0.00% | $215K | $35.98 |
| 2022 Q4 | REDUCED | 1,200 | -5,100 | -81.0% | 0.00% | $53K | $44.57 |
| 2021 Q4 | UNCHANGED | 6,300 | — | 0% | 0.00% | $243K | $38.64 |
| 2021 Q3 | INITIATED | 6,300 | — | — | 0.00% | $340K | $53.99 |
As of 2025 Q4 — sorted by position size